Drug CEO Who Hiked Pill Price Has History of Serious ‘Harassment'

The pharmaceutical company boss who jacked up the price of the drug Daraprim 5,500 percent overnight allegedly has a history of "harassment" to a former employee, according to court documents. 

Martin Shkreli, 32, said on Friday that he would be lowering the new price but did not clarify what the new price would be, NBC News reported.

Shkreli allegedly gained access to social media accounts of an ex-employee and contacted his relatives, including his teenage son and wife, accusing him of stealing money from Shrkeli's then pharmaceutical company, Retrophin. 

"Your husband had stolen $1.6 million from me and I will get it back. I will go to any length necessary to get it back," Shkreli allegedly wrote the wife of former Retrophin employee Timothy Pierotti in a January 2013 letter, according to court documents.

"Your pathetic excuse of a husband needs to get a real job that does not depend on fraud to succeed. ... I hope to see you and your four children homeless and will do whatever I can to assure this," Shkreli allegedly wrote.

Retrophin's board later moved to replace Shkreli as CEO, and he resigned his positions. Retrophin is now suing him for $65 million in a case where he is accused of acting against the interests of the company.

Contact Us